Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ETRAVIRINE for Maternal exposure timing unspecified: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where ETRAVIRINE was used for Maternal exposure timing unspecified.

Most Reported Side Effects for ETRAVIRINE

Side Effect Reports % Deaths Hosp.
Drug resistance 208 10.6% 100 14
Treatment failure 186 9.5% 97 0
Virologic failure 186 9.5% 5 17
Death 150 7.6% 149 5
Viral mutation identified 141 7.2% 0 0
Foetal exposure during pregnancy 135 6.9% 9 19
Lipodystrophy acquired 118 6.0% 0 14
Pathogen resistance 117 5.9% 0 2
Cd4/cd8 ratio decreased 96 4.9% 96 0
Cd4 lymphocytes decreased 93 4.7% 77 9
Eyelid ptosis 84 4.3% 0 3
Exposure during pregnancy 83 4.2% 0 6
Mitochondrial toxicity 82 4.2% 1 1
Diplopia 81 4.1% 0 0
Maternal exposure during pregnancy 80 4.1% 0 3

Other Indications for ETRAVIRINE

Hiv infection (1,379) Product used for unknown indication (377) Antiretroviral therapy (44) Hiv test positive (16) Friedreich's ataxia (10) Antiviral treatment (6) Hepatitis c (6) Acquired immunodeficiency syndrome (5) Hepatitis viral (5)

Other Drugs Used for Maternal exposure timing unspecified

VALPROATE (1,477) ADALIMUMAB (1,280) NATALIZUMAB (492) RITONAVIR (486) EMTRICITABINE\TENOFOVIR DISOPROXIL (333) LOPINAVIR\RITONAVIR (278) DIVALPROEX (254) INTERFERON BETA-1A (245) DIMETHYL (212) ATAZANAVIR (169)

Related Pages

ETRAVIRINE Full Profile All Maternal exposure timing unspecified Drugs ETRAVIRINE Demographics ETRAVIRINE Timeline